Other targets linked to hypoxia such as Cdkn2a (cyclin-dependent kinase inhibitor 2A) or Vdac1 (voltage-dependent anion-selective channel 1) [198,199] were identified in an innovative approach aiming to explore novel biomarkers for lung cancer in exhaled breath [200,201]. This evidence concerns the gene CDKN2A and lung cancer.